Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kazia Therapeutics (KZIA) Pension (2021 - 2025)

Kazia Therapeutics (KZIA) posted Pension of $23696.0 for Q2 2025, down 90.44% on a QoQ basis from $247745.6 in Q4 2024, and up 2.73% year-over-year from $23065.9 in Q2 2024.

Kazia Therapeutics (KZIA) has 5 years of Pension data on file, last reported at $23696.0 in Q2 2025.

  • In Q2 2025, Pension rose 2.73% year-over-year to $23696.0; the TTM figure through Jun 2025 stood at $23696.0 (up 2.73% YoY), while the FY2025 annual figure was $23696.0, up 2.73% from the prior year.
  • Pension eased to $23696.0 in Q2 2025, from $247745.6 in the prior quarter.
  • Across five years, Pension topped out at $290952.3 in Q4 2022 and bottomed at $23065.9 in Q2 2024.
  • A 5-year average of $139423.7 and a median of $131003.5 in 2021 frame the typical range for Pension.
  • Annual changes were most pronounced in 2022 — Pension surged 439.49% — and 2023, when it plunged 82.74%.
  • Year by year, Pension stood at $42353.0 in 2021, then soared by 586.97% to $290952.3 in 2022, then fell by 24.51% to $219654.0 in 2023, then grew by 12.79% to $247745.6 in 2024, then slumped by 90.44% to $23696.0 in 2025.
  • The last three Pension figures came in at $23696.0 (Q2 2025), $247745.6 (Q4 2024), and $23065.9 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Kazia Therapeutics 1.55 Bn 1.55 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 23,696.03
Dec 31, 2024 247,745.57
Jun 30, 2024 23,065.86
Dec 31, 2023 219,653.95
Jun 30, 2023 39,433.27
Dec 31, 2022 290,952.25
Jun 30, 2022 228,489.60
Jun 30, 2021 42,353.03